Trial NCT02011126

View at ClinicalTrials.gov 
Org. Study IDs: ADVL1321
Secondary IDs: ADVL1321 NCI-2013-01640 U10CA098543

Last trial update was posted on 2018-08-07

MeSH Interventions

Imetelstat Motesanib diphosphate

MeSH Conditions

Hepatoblastoma Neuroblastoma Neuroectodermal Tumors Neuroectodermal Tumors, Primitive Neuroectodermal Tumors, Primitive, Peripheral Osteosarcoma Recurrence Rhabdomyosarcoma Rhabdomyosarcoma, Embryonal Sarcoma, Ewing

Other Conditions

Previously Treated Childhood Rhabdomyosarcoma Recurrent Childhood Liver Cancer Recurrent Childhood Rhabdomyosarcoma Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Recurrent Neuroblastoma Recurrent Osteosarcoma

Stopping Reasons

IND no longer available.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID